Anderson Collier
Pediatric Hematology-Oncology · Jackson, MSNPI 1992892020
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,490 of the $1,989 with a category attached, or 74.9%. 20 manufacturers reported payments, led by Novartis at 49.2% of the total. 2025 is the largest year on record at $906, 2.4 times the $373 reported in 2019.
Across 48 payments — averaging $41.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$979
- Sobi, Inc$212
- Shire North American Group Inc$135
- Janssen Scientific Affairs, LLC$124
- Pfizer$72
- Jazz Pharmaceuticals Inc.$64
- plus $404 from 14 others
Across 69 payments — averaging $8603.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$391K
- Pfizer$151K
- Eisai Inc.$17K
- E.r. Squibb & Sons, L.L.C.$16K
- Novartis$10K
- Incyte Corporation$5K
- plus $4K from 2 others
What the payments were for
- Travel & lodging$49925%
- Food & beverage$1,49075%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $979 |
| Sobi, Inc | 5 | $212 |
| Shire North American Group Inc | 1 | $135 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Pfizer | 4 | $72 |
| Jazz Pharmaceuticals Inc. | 3 | $64 |
| Servier Pharmaceuticals LLC | 5 | $60 |
| Novo Nordisk | 3 | $54 |
| Genetix Biotherapeutics Inc | 2 | $42 |
| Bayer | 2 | $42 |
| AstraZeneca | 1 | $32 |
| Amgen | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Seagen Inc. | 1 | $22 |
| Global Blood Therapeutics, Inc. | 1 | $17 |
| ADMA Biomanufacturing LLC | 1 | $17 |
| Emmaus Medical, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| CSL Behring | 1 | $15 |
| ADC Therapeutics America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in Jackson
- Betty HerringtonJackson$23K
- Laura ArnoldJackson$2K
- Catherine GordonJackson$1K
- Amanda StrobelJackson$731
- Melissa McNaullJackson$388
- Rathi IyerJackson$61
- Spencer SullivanMadison$92K
- Sharon PenningtonFlowood$17K
- Mauricio Rendon BernotPicayune$47
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.